We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.

Global Pharmacovigilance and Drug Safety Software Market

Market Overview:
The global Pharmacovigilance and Drug Safety Software Market was valued at USD 127.18 million in 2016 and is projected to reach USD 222.83 million by 2025, growing at a CAGR of 6.43% from 2017 to 2025.

Pharmacovigilance software is a drug safety management software solution that supports case management, report preparation, electronic submissions and benefit & risk management as per the guidelines set by ICH, FDA, EMA and other national authorities.

Sample Infographics:




Market Dynamics:
1. Market Drivers
1.1 Increasing drug discoveries and technical advancements
1.2 Growing cases of chronic diseases
1.3 Growing geriatric population
1.4 High reports of Drug reactions
1.5 Government safety concerns towards adverse drug results

2. Market Restraints
2.1 Lack of regulations
2.2 Lack of pharmacovigilance professionals

Market Segmentation:
1. Global Pharmacovigilance and Drug Safety Software Market, by Delivery:
1.1 On-Premise Delivery Mode
1.2 On-Demand/Cloud Based (Saas) Delivery Mode

2. Global Pharmacovigilance and Drug Safety Software Market, by Functionality:
2.1 Adverse Event Reporting Software
2.2 Drug Safety Audits Software
2.3 Issue Tracking Software
2.4 Fully Integrated Software

3. Global Pharmacovigilance and Drug Safety Software Market, by End User:
3.1 Pharma and Biotech Companies
3.2 Contract Research Organizations (CROS)
3.3 Business Process Outsourcing (BPO) Firms
3.4 Other Pharmacovigilance Service Providers

4. Global Pharmacovigilance and Drug Safety Software Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. AB-Cube
2. Arisglobal
3. Extedo GMBH.
4. Ennov.
5. Online Business Applications, Inc
6. Oracle Corporation.
7. Sarjen Systems Pvt. Ltd
8. Sparta Systems, Inc
9. United Biosource Corporation
10. Umbra Global

These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Pharmacovigilance and Drug Safety Software Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.

1 INTRODUCTION OF GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY DELIVERY
5.1 Overview
5.2 On-Premise Delivery Mode
5.3 On-Demand/Cloud Based (Saas) Delivery Mode

6 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY FUNCTIONALITY
6.1 Overview
6.2 Adverse Event Reporting Software
6.3 Drug Safety Audits Software
6.4 Issue Tracking Software
6.5 Fully Integrated Software

7 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY END USER
7.1 Overview
7.2 Pharma and Biotech Companies
7.3 Contract Research Organizations (CROS)
7.4 Business Process Outsourcing (BPO) Firms
7.5 Other Pharmacovigilance Service Providers

8 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025

9 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES
10.1 AB-Cube
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments

10.2 Arisglobal
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments

10.3 Extedo GMBH
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments

10.4 Ennov
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments

10.5 Online Business Applications, Inc
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments

10.6 Oracle Corporation
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments

10.7 Sarjen Systems Pvt. Ltd
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments

10.8 Sparta Systems, Inc
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments

10.9 United Biosource Corporation
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments

10.10 Umbra Global
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments

11 Appendix
11.1 Related Reports

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved